Under Multiple Sclerosis section from NICE Technology Appraisal published on 2007
Natalizumab for the treatment of adults with highly active relapsing-remitting multiple sclerosis
Docplexus Admin
Medical Writer
Join the community and view the full post,
write comments and share this post.
🩺 India's Largest Platform for Doctors
✅ 5,10,000+ Verified Doctors
💬 60,000+ Clinical Discussions